Is there a simple version of how sema vs tirz are different — looking for input

newstart_MO said:

Amycretin (AMY/GLP-1 dual agonist) emerging data relevant to the pharmacology: Phase 1 showed -13.1% body weight at only 12 weeks, the fastest…

Genuinely useful, thank you. I had the facts and not the framework.

Adding the clinical framing, because it changes how the question reads. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

LindaRN_retired said:

I want to add the drug interaction perspective on the pharmacology.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.